Key statistics
On Friday, Profound Medical Corp (PRN:TOR) closed at 8.90, -28.23% below its 52-week high of 12.40, set on Jan 13, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 8.50 |
|---|---|
| High | 9.17 |
| Low | 8.50 |
| Bid | 8.84 |
| Offer | 9.72 |
| Previous close | 8.50 |
| Average volume | 19.84k |
|---|---|
| Shares outstanding | 36.29m |
| Free float | 32.17m |
| P/E (TTM) | -- |
| Market cap | 323.25m CAD |
| EPS (TTM) | -1.82 CAD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
- Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
- Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease
- PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health
- Profound Medical Announces Upcoming Investor Events
- Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®
- Profound Surpasses 2025 TULSA-PRO® Installed Base Goal
- Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case
- Profound Medical Corp. Announces Closing of Private Placement
- Profound Medical Corp. Announces Upsize of Private Placement
- Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
More ▼
